Stephen Kimmel
Affiliations: | Epidemiology and Biostatistics | University of Pennsylvania, Philadelphia, PA, United States |
Area:
EpidemiologyGoogle:
"Stephen Kimmel"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Johnson JA, Caudle KE, Gong L, et al. (2017) Clinical pharmacogenetics implementation consortium (cpic) guideline for pharmacogenetics-guided warfarin dosing: 2017 update. Clinical Pharmacology and Therapeutics |
| Finkelman BS, French B, Bershaw L, et al. (2016) Predicting prolonged dose titration in patients starting warfarin. Pharmacoepidemiology and Drug Safety |
| Finkelman BS, French B, Kimmel SE. (2016) The prediction accuracy of dynamic mixed-effects models in clustered data. Biodata Mining. 9: 5 |
| Finkelman BS, French B, Bershaw L, et al. (2015) Factors affecting time to maintenance dose in patients initiating warfarin. Pharmacoepidemiology and Drug Safety. 24: 228-36 |
| Li RC, Finkelman BS, Chen J, et al. (2013) Dietary vitamin K intake and anticoagulation control during the initiation phase of warfarin therapy: a prospective cohort study. Thrombosis and Haemostasis. 110: 195-6 |
| Finkelman BS, Gage BF, Johnson JA, et al. (2011) Genetic warfarin dosing: tables versus algorithms. Journal of the American College of Cardiology. 57: 612-8 |
| Schelleman H, Brensinger CM, Chen J, et al. (2010) New genetic variant that might improve warfarin dose prediction in African Americans British Journal of Clinical Pharmacology. 70: 393-399 |
| Lenzini P, Wadelius M, Kimmel S, et al. (2010) Integration of genetic, clinical, and INR data to refine warfarin dosing. Clinical Pharmacology and Therapeutics. 87: 572-8 |